NCT07137728

Brief Summary

The goal of this clinical trial is to determine whether dual frequency low-level laser therapy can reduce pain, improve function, and increase neck movement in patients with myofascial trigger points in the upper trapezius muscle. The study includes men and women aged 20 to 55 years who have been diagnosed with upper trapezius myofascial pain syndrome. The main questions it aims to answer are:

  • Does dual frequency low-level laser therapy reduce pain more effectively than single wavelength laser therapy?
  • Does dual frequency low-level laser therapy improve functional ability and cervical range of motion more than other treatments? Researchers compared three groups of participants receiving different treatments to evaluate their effects. Participants were randomly assigned to one of three groups:
  • Group A received red wavelength low-level laser therapy with conventional physiotherapy
  • Group B received infrared low-level laser therapy with conventional physiotherapy
  • Group C received dual frequency low-level laser therapy with conventional physiotherapy All participants received treatment twice weekly for four weeks. Conventional therapy included stretching exercises, strengthening exercises, and postural correction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 2, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 15, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 22, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2026

Completed
Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

August 15, 2025

Last Update Submit

April 15, 2026

Conditions

Keywords

Low-Level Lazer TherapyDual Frequency LaserUpper Trapezius MuscleMyofascial Trigger PointsMyofascial Pain SyndromeNeck PainPhotobiomodulationPhysical Therapy Intervention

Outcome Measures

Primary Outcomes (3)

  • Pain Intensity (Visual Analog Scale)

    Pain intensity was measured using the Visual Analogue Scale (VAS), a 0-10 scale where higher scores indicate greater pain intensity.

    Baseline, Week 2, Week 4

  • Functional Disability (Neck Disability Index)

    Functional disability was assessed using the Neck Disability Index (NDI), which evaluates the impact of neck pain on daily activities.

    Baseline, Week 2, Week 4

  • Cervical Range of Motion

    Cervical range of motion (flexion, extension, lateral flexion, and rotation) was measured using a goniometer.

    Baseline, Week 2, Week 4

Study Arms (3)

Red Low-Level Laser Therapy

EXPERIMENTAL

Participants received red wavelength low-level laser therapy (660 nm) combined with conventional physiotherapy including stretching, strengthening, and postural correction exercises.

Device: Red Low-Level Laser TherapyOther: Conventional Therapy

Infrared Low-Level Laser Therapy

EXPERIMENTAL

Participants received infrared low-level laser therapy (830 nm) combined with conventional physiotherapy.

Device: Infrared Low-Level Laser TherapyOther: Conventional Therapy

Dual Frequency Low-Level Laser Therapy

EXPERIMENTAL

Participants received dual frequency low-level laser therapy (660 nm and 830 nm) combined with conventional physiotherapy.

Device: Dual Frequency Low-Level Laser TherapyOther: Conventional Therapy

Interventions

Dual frequency laser therapy combining red (660 nm) and infrared (830 nm) wavelengths was applied sequentially to trigger points with a dose of 5 J/cm² per wavelength, twice weekly for four weeks.

Dual Frequency Low-Level Laser Therapy

Red wavelength (660 nm) low-level laser therapy was applied to upper trapezius trigger points at a dose of 5 J/cm², frequency 9-10 Hz, for 60-100 seconds per point, twice weekly for four weeks.

Red Low-Level Laser Therapy

Infrared wavelength (830 nm) low-level laser therapy was applied to trigger points at a dose of 5 J/cm² for approximately 3 minutes per point, twice weekly for four weeks.

Infrared Low-Level Laser Therapy

Conventional physiotherapy included stretching exercises, isometric strengthening, and postural correction techniques.

Dual Frequency Low-Level Laser TherapyInfrared Low-Level Laser TherapyRed Low-Level Laser Therapy

Eligibility Criteria

Age20 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Men and women aged 20-55 years.
  • Diagnosis of myofascial pain based on Simons criteria.
  • At least two trigger points in the upper trapezius muscle.
  • Pain duration ≥ 3 months.
  • VAS pain score ≥ 5.
  • Limited cervical range of motion (40-60%) due to trigger points.

You may not qualify if:

  • Pregnancy.
  • Use of anticoagulants.
  • Bleeding disorders or dermatological diseases at treatment site.
  • History of infectious, inflammatory, tumoral, cardiopulmonary, psychiatric, or systemic diseases.
  • Kellgren stage 3-4 cervical osteoarthritis or cervical disc herniation causing radiculopathy.
  • Diagnosis of fibromyalgia.
  • Inability to follow instructions or complete questionnaires.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MoveNow Physiotherapy and Rehabilitation Centre

Lahore, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Myofascial Pain SyndromesNeck Pain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor was blinded to group allocation to reduce assessment bias.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly allocated into three parallel groups receiving red wavelength low-level laser therapy, infrared low-level laser therapy, or dual frequency low-level laser therapy, each combined with conventional physiotherapy.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 15, 2025

First Posted

August 22, 2025

Study Start

June 2, 2025

Primary Completion

February 28, 2026

Study Completion

March 2, 2026

Last Updated

April 21, 2026

Record last verified: 2026-04

Locations